Marksans Pharma Limited (BOM: 524404)
India flag India · Delayed Price · Currency is INR
316.45
-4.50 (-1.40%)
At close: Dec 19, 2024

Marksans Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Net Income
3,4703,1372,6631,8682,3851,208
Upgrade
Depreciation & Amortization
827.97740.55518.53447.76307.69215.71
Upgrade
Other Amortization
2.152.15--5.925.92
Upgrade
Loss (Gain) From Sale of Assets
-0.22-0.942.64--0.37-0.25
Upgrade
Asset Writedown & Restructuring Costs
----47.944.98
Upgrade
Loss (Gain) From Sale of Investments
108.28-43.63108.02-56.23-16.250.45
Upgrade
Provision & Write-off of Bad Debts
73.3251.57143.6126.32142.83-
Upgrade
Other Operating Activities
-539.35-320.7152.89-186.4228.9267.75
Upgrade
Change in Accounts Receivable
-816.89-371.67-275.18-1,039-367.44-667.55
Upgrade
Change in Inventory
-1,697-1,127-448.5-178.49-1,392514.02
Upgrade
Change in Accounts Payable
---284.79417.84665.73
Upgrade
Change in Other Net Operating Assets
741.06236.48-390.97-173.9825.7578.96
Upgrade
Operating Cash Flow
2,1692,3042,374992.571,7862,333
Upgrade
Operating Cash Flow Growth
-14.21%-2.95%139.19%-44.42%-23.46%751.71%
Upgrade
Capital Expenditures
-1,649-2,088-536.31-463.3-464.26-599.09
Upgrade
Sale of Property, Plant & Equipment
16.358.543.770.345.22.82
Upgrade
Cash Acquisitions
---266.1---
Upgrade
Investment in Securities
-494.01-259.48-1-428.55--
Upgrade
Other Investing Activities
946.48930.92-1,79247.610.570.43
Upgrade
Investing Cash Flow
-1,180-1,408-2,592-843.91-448.49-595.84
Upgrade
Short-Term Debt Issued
--52.96225.52--
Upgrade
Long-Term Debt Issued
-----107.62
Upgrade
Total Debt Issued
--52.96225.52-107.62
Upgrade
Short-Term Debt Repaid
--124.97---1.03-810.66
Upgrade
Long-Term Debt Repaid
--284-207.73-155.17-31.03-
Upgrade
Total Debt Repaid
-444.89-408.97-207.73-155.17-32.06-810.66
Upgrade
Net Debt Issued (Repaid)
-444.89-408.97-154.7770.35-32.06-703.05
Upgrade
Repurchase of Common Stock
---321.14---
Upgrade
Common Dividends Paid
-271.9-226.58-101.71-105.83-40.93-295.03
Upgrade
Dividends Paid
-271.9-226.58-101.71-105.83-40.93-295.03
Upgrade
Other Financing Activities
-47.25-51.722,606830.59-79.86-87.46
Upgrade
Financing Cash Flow
-764.04-687.271,978795.11-152.85-1,136
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.02---
Upgrade
Net Cash Flow
224.94208.41,760943.771,185601.89
Upgrade
Free Cash Flow
520.15215.691,838529.271,3221,734
Upgrade
Free Cash Flow Growth
-41.80%-88.26%247.23%-59.95%-23.79%1117.10%
Upgrade
Free Cash Flow Margin
2.19%0.99%9.92%3.55%9.60%15.29%
Upgrade
Free Cash Flow Per Share
1.150.484.421.293.234.24
Upgrade
Cash Interest Paid
47.2551.7260.6680.9679.8649.7
Upgrade
Cash Income Tax Paid
1,4921,223630.14728.59485.3250
Upgrade
Levered Free Cash Flow
-712.84-510.23661.16-227.75528.631,373
Upgrade
Unlevered Free Cash Flow
-628.1-440.21699.26-191.87552.491,409
Upgrade
Change in Net Working Capital
2,4581,4961,0811,5141,229-722.6
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.